298 related articles for article (PubMed ID: 11312327)
1. Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.
Leroux C; Craigo JK; Issel CJ; Montelaro RC
J Virol; 2001 May; 75(10):4570-83. PubMed ID: 11312327
[TBL] [Abstract][Full Text] [Related]
2. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony.
Leroux C; Issel CJ; Montelaro RC
J Virol; 1997 Dec; 71(12):9627-39. PubMed ID: 9371627
[TBL] [Abstract][Full Text] [Related]
3. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.
Howe L; Leroux C; Issel CJ; Montelaro RC
J Virol; 2002 Nov; 76(21):10588-97. PubMed ID: 12368301
[TBL] [Abstract][Full Text] [Related]
4. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC
Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113
[TBL] [Abstract][Full Text] [Related]
5. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.
Hammond SA; Li F; McKeon BM; Cook SJ; Issel CJ; Montelaro RC
J Virol; 2000 Jul; 74(13):5968-81. PubMed ID: 10846078
[TBL] [Abstract][Full Text] [Related]
6. Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony.
Belshan M; Baccam P; Oaks JL; Sponseller BA; Murphy SC; Cornette J; Carpenter S
Virology; 2001 Jan; 279(1):185-200. PubMed ID: 11145901
[TBL] [Abstract][Full Text] [Related]
7. Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection.
Mealey RH; Leib SR; Pownder SL; McGuire TC
J Virol; 2004 Sep; 78(17):9295-305. PubMed ID: 15308724
[TBL] [Abstract][Full Text] [Related]
8. Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus.
Lichtenstein DL; Issel CJ; Montelaro RC
J Virol; 1996 Jun; 70(6):3346-54. PubMed ID: 8648664
[TBL] [Abstract][Full Text] [Related]
9. Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.
Harrold SM; Cook SJ; Cook RF; Rushlow KE; Issel CJ; Montelaro RC
J Virol; 2000 Apr; 74(7):3112-21. PubMed ID: 10708426
[TBL] [Abstract][Full Text] [Related]
10. Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication.
Craigo JK; Leroux C; Howe L; Steckbeck JD; Cook SJ; Issel CJ; Montelaro RC
J Gen Virol; 2002 Jun; 83(Pt 6):1353-1359. PubMed ID: 12029150
[TBL] [Abstract][Full Text] [Related]
11. Apparent elimination of EIAV ancestral species in a long-term inapparent carrier.
Craigo JK; Sturgeon TJ; Cook SJ; Issel CJ; Leroux C; Montelaro RC
Virology; 2006 Jan; 344(2):340-53. PubMed ID: 16226288
[TBL] [Abstract][Full Text] [Related]
12. A unique evolution of the s2 gene of equine infectious anemia virus in hosts correlated with particular infection statuses.
Wang XF; Wang S; Liu Q; Lin YZ; Du C; Tang YD; Na L; Wang X; Zhou JH
Viruses; 2014 Nov; 6(11):4265-79. PubMed ID: 25390683
[TBL] [Abstract][Full Text] [Related]
13. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine.
Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J
Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668
[TBL] [Abstract][Full Text] [Related]
14. Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection.
Salinovich O; Payne SL; Montelaro RC; Hussain KA; Issel CJ; Schnorr KL
J Virol; 1986 Jan; 57(1):71-80. PubMed ID: 3001367
[TBL] [Abstract][Full Text] [Related]
15. Immune selection of equine infectious anemia virus env variants during the long-term inapparent stage of disease.
Sponseller BA; Sparks WO; Wannemuehler Y; Li Y; Antons AK; Oaks JL; Carpenter S
Virology; 2007 Jun; 363(1):156-65. PubMed ID: 17328936
[TBL] [Abstract][Full Text] [Related]
16. Horses naturally infected with EIAV harbor 2 distinct SU populations but are monophyletic with respect to IN.
Cervantes DT; Ball JM; Edwards J; Payne S
Virus Genes; 2016 Feb; 52(1):71-80. PubMed ID: 26739458
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation of envelope gp90 gene of equine infectious anemia virus isolated from an experimentally infected horse.
Pang H; Kong XG; Sentsui H; Kono Y; Sugiura T; Hasegawa A; Akashi H
J Vet Med Sci; 1997 Dec; 59(12):1089-95. PubMed ID: 9450237
[TBL] [Abstract][Full Text] [Related]
18. Insertions, duplications and substitutions in restricted gp90 regions of equine infectious anaemia virus during febrile episodes in an experimentally infected horse.
Zheng YH; Nakaya T; Sentsui H; Kameoka M; Kishi M; Hagiwara K; Takahashi H; Kono Y; Ikuta K
J Gen Virol; 1997 Apr; 78 ( Pt 4)():807-20. PubMed ID: 9129653
[TBL] [Abstract][Full Text] [Related]
19. Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?
Leroux C; Cadoré JL; Montelaro RC
Vet Res; 2004; 35(4):485-512. PubMed ID: 15236678
[TBL] [Abstract][Full Text] [Related]
20. Specificity of serum neutralizing antibodies induced by transient immune suppression of inapparent carrier ponies infected with a neutralization-resistant equine infectious anemia virus envelope strain.
Howe L; Craigo JK; Issel CJ; Montelaro RC
J Gen Virol; 2005 Jan; 86(Pt 1):139-149. PubMed ID: 15604441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
